|
ISRCTN
|
ISRCTN79164268
|
|
ClinicalTrials.gov identifier
|
|
|
Public title
|
Evaluation of the necessary frequency of blood glucose self-monitoring in type 2 diabetic patients. A prospective, controlled, randomised, multicenter study.
|
|
Scientific title
|
|
|
Acronym
|
N/A
|
|
Serial number at source
|
N/A
|
|
Study hypothesis
|
To evaluate the impact of the frequency of blood glucose self-monitoring on glycaemic control (HbA1c and occurrence of hypoglycaemia) of type 2 diabetic patients. Currently there are no general recommendations on the frequency of self blood glucose monitoring in type 2 diabetics treated with a fixed insulin regime or oral antidiabetic medication. The study intends to compare over a follow-up period of 6 month patients with a high frequency of self-monitoring with those with a low frequency. This comparison is done separately for two groups of patients:
1. Treated with a fixed insulin regime
2. Treated with oral antidiabetic drugs only
Satisfaction with the recommended treatment is a secondary endpoint of the study.
|
|
Ethics approval
|
Not provided at time of registration
|
|
Study design
|
Randomised controlled trial
|
|
Countries of recruitment
|
Germany
|
|
Disease/condition/study domain
|
Type 2 diabetes mellitus
|
|
Participants - inclusion criteria
|
1. Patients treated with a fixed dose of mixture insulin twice a day
2. Patients who are treated with one or more oral antidiabetic drugs
3. From 35 to 80 years
4. Informed consent
5. Type 2 diabetic patients
|
|
Participants - exclusion criteria
|
1. Treatment with multiple insulin injections (more than 2/day)
2. Type 1 diabetic patients
3. Advanced renal insufficiency (known creatinine >2.5 mg/dl)
4. >2 hypoglycaemia with necessary outside help within the last three months
5. Hypoglycaemic shock/hyperosmolaric coma within the last three months
6. Pregnancy
7. Severe impaired vision
8. Communication problems
9. Home care/nursing service
|
|
Anticipated start date
|
01/12/2003
|
|
Anticipated end date
|
01/10/2006
|
|
Status of trial
|
Completed |
|
Patient information material
|
|
|
Target number of participants
|
400 (100 in each group)
|
|
Interventions
|
Blood glucose monitoring
1. Patients on insulin mixture:
1.1 Maximum recommendation: every day fasting, every second day before dinner, additional once a profile
1.2 Minimum recommendation: once a week a fasting blood glucose
2. Patients who get an oral antidiabetic:
2.1 Maximum recommendation: every second day a fasting blood glucose, once a week a blood sugar check before dinner
2.2 Minimum recommendation: one fasting blood glucose per week
|
|
Primary outcome measure(s)
|
HbA1c six months after start of the study
|
|
Secondary outcome measure(s)
|
1. Hypoglycaemia with necessary outside help
2. Hyperosmolar coma
3. Quality of life
4. Compliance
5. HbA1c after 12 months
|
|
Sources of funding
|
Federal Ministry of Education and Research (Bundesministerium Für Bildung und Forschung [BMBF]) - Germany - 01GL0303
|
|
Trial website
|
|
|
Publications
|
Results: http://www.ncbi.nlm.nih.gov/pubmed/18769484
|
|
Contact name
|
Prof
Werner A.
Scherbaum
|
|
Address
|
Deutsches Diabetes Zentrum an der Heinrich-Heine-Universität
Auf´m Hennekamp 65
|
|
City/town
|
Duesseldorf
|
|
Zip/Postcode
|
40225
|
|
Country
|
Germany
|
|
Tel
|
+49 (0)2113382-200
|
|
Fax
|
+49 (0)2113369103
|
|
Email
|
scherbaum@ddz.uni-duesseldorf.de
|
|
Sponsor
|
Federal Ministry of Education and Research (Bundesministerium Für Bildung und Forschung [BMBF]) (Germany)
|
|
Address
|
Südstrasse 125
|
|
City/town
|
Bonn
|
|
Zip/Postcode
|
53175
|
|
Country
|
Germany
|
|
Tel
|
+49 (0)2283821202
|
|
Fax
|
+49 (0)2283821257
|
|
Email
|
cornelia.bormann@dlr.de
|
|
Date applied
|
05/09/2005
|
|
Last edited
|
09/09/2008
|
|
Date ISRCTN assigned
|
28/10/2005
|